Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jesse Mez

Showing results (81-90 of 254) with videos related to

Pageof 26
Sort By:
Annals of Epidemiology|June 16, 2019
Initiation of antidepressant medication and risk of incident stroke: using the Adult Changes in Thought cohort to address time-varying confoundingM Maria Glymour, Laura E Gibbons, Paola Gilsanz, et al.
Neurology|July 16, 2021
Impact of C-Reactive Protein on Cognition and Alzheimer Disease Biomarkers in Homozygous <i>APOE</i> ɛ4 CarriersQiushan Tao, Ting Fang Alvin Ang, Samia C Akhter-Khan, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|October 7, 2017
Alzheimer's disease genetic risk variants beyond <i>APOE</i> ε4 predict mortalityJesse Mez, Jessica R Marden, Shubhabrata Mukherjee, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|May 11, 2023
Alzheimer's disease heterogeneity explained by polygenic risk scores derived from brain transcriptomic profilesJaeyoon Chung, Nathan Sahelijo, Toru Maruyama, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|November 13, 2004
A mutant ataxin-3 putative-cleavage fragment in brains of Machado-Joseph disease patients and transgenic mice is cytotoxic above a critical concentrationDaniel Goti, Scott M Katzen, Jesse Mez, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|November 17, 2022
Blood levels of MCP-1 modulate the genetic risks of Alzheimer's disease mediated by HLA-DRB1 and APOE for Alzheimer's diseaseJinghan Huang, Thor D Stein, Yixuan Wang, et al.
Neurology|June 28, 2020
Late contributions of repetitive head impacts and TBI to depression symptoms and cognitionMichael L Alosco, Yorghos Tripodis, Zachary H Baucom, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|October 28, 2025
Higher vitamin B<sub>12</sub> from mid- to late life is related to slower rates of cognitive declineFrancesca R Marino, Gail Rogers, Joshua W Miller, et al.
Translational Psychiatry|December 22, 2022
The impact of increasing levels of blood C-reactive protein on the inflammatory loci SPI1 and CD33 in Alzheimer's diseaseJinghan Huang, Qiushan Tao, Ting Fang Alvin Ang, et al.
Neurobiology of Aging|April 23, 2016
The executive prominent/memory prominent spectrum in Alzheimer's disease is highly heritableJesse Mez, Shubhabrata Mukherjee, Timothy Thornton, et al.
Pageof 26

Showing results (81-90 of 254) with videos related to

Sort By:
Pageof 26
Annals of Epidemiology|June 16, 2019
Initiation of antidepressant medication and risk of incident stroke: using the Adult Changes in Thought cohort to address time-varying confoundingM Maria Glymour, Laura E Gibbons, Paola Gilsanz, et al.
Neurology|July 16, 2021
Impact of C-Reactive Protein on Cognition and Alzheimer Disease Biomarkers in Homozygous <i>APOE</i> ɛ4 CarriersQiushan Tao, Ting Fang Alvin Ang, Samia C Akhter-Khan, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|October 7, 2017
Alzheimer's disease genetic risk variants beyond <i>APOE</i> ε4 predict mortalityJesse Mez, Jessica R Marden, Shubhabrata Mukherjee, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|May 11, 2023
Alzheimer's disease heterogeneity explained by polygenic risk scores derived from brain transcriptomic profilesJaeyoon Chung, Nathan Sahelijo, Toru Maruyama, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|November 13, 2004
A mutant ataxin-3 putative-cleavage fragment in brains of Machado-Joseph disease patients and transgenic mice is cytotoxic above a critical concentrationDaniel Goti, Scott M Katzen, Jesse Mez, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|November 17, 2022
Blood levels of MCP-1 modulate the genetic risks of Alzheimer's disease mediated by HLA-DRB1 and APOE for Alzheimer's diseaseJinghan Huang, Thor D Stein, Yixuan Wang, et al.
Neurology|June 28, 2020
Late contributions of repetitive head impacts and TBI to depression symptoms and cognitionMichael L Alosco, Yorghos Tripodis, Zachary H Baucom, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|October 28, 2025
Higher vitamin B<sub>12</sub> from mid- to late life is related to slower rates of cognitive declineFrancesca R Marino, Gail Rogers, Joshua W Miller, et al.
Translational Psychiatry|December 22, 2022
The impact of increasing levels of blood C-reactive protein on the inflammatory loci SPI1 and CD33 in Alzheimer's diseaseJinghan Huang, Qiushan Tao, Ting Fang Alvin Ang, et al.
Neurobiology of Aging|April 23, 2016
The executive prominent/memory prominent spectrum in Alzheimer's disease is highly heritableJesse Mez, Shubhabrata Mukherjee, Timothy Thornton, et al.
Pageof 26